[1] Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res. 1998; 83(1):15-26. [2] Kajstura J, Leri A, Finato N, et al. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A.1998; 95(15):8801-8805. [3] Beltrami AP,Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344(23):1750-1757.[4] Urbanek K, Torella D, Sheikh F, et al. Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A. 2005;102(24): 8692-8697. [5] Urbanek K, Rota M, Cascapera S, et al. Cardiac stem cells possess growth factor-receptor systems that following activation regenerate the infarcted myocardium improving ventricular function and long-term survival. Circ Res. 2005; 97(7):663-673.[6] Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res.2004;95(9):911-921.[7] Linke A, Muller P, Nurzynska D, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A. 2005;102(25):8966-8971.[8] Johnston PV, Sasano T, Mills K, et al. Engraftment, and functional benefits of autologous cardiosphere-derived differentiation,cells in porcine ischemic cardiomyopathy. Circulation 2009;120(12):1075-1083.[9] He JQ, Vu DM, Hunt G, et al. Human Cardiac Stem Cells Isolated from Atrial Appendages Stably Express c-kit. PLoS One. 2011;6(11):e27719.[10] Bollini S, Smart N, Riley PR, et al. Resident cardiac progenitor cells: at the heart of regeneration. J Mol Cell Cardiol. 2011;50(2):296-303.[11] Beltrami AP,Barlucchi L,Torella D,et al. Adult cardiac stem cells are muhipotent and support myocardial regeneration. Cell. 2003;1(14):763-776.[12] Matsuura K, Nagai T, Nishigaki N, et al. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem.2004; 279(12):11384-11391.[13] Huang C, Gu H, Yu Q, et al. Sca-1+ Cardiac Stem Cells Mediate Acute Cardioprotection via Paracrine Factor SDF-1 following Myocardial Ischemia/Reperfusion. PLoS ONE. 2011; 6(12): e29246.[14] Bu L, Jiang X, Martin-Puig S, et al. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature. 2009;460(7251):113-117.[15] Liang SX, Tan TY, Gaudry L, et al. Differentiation and migration of Sca1+/CD31- cardiac side population cells in a murine myocardial ischemic model. Int J Cardiol. 2010;138(1): 40-49.[16] Yamahara K, Fukushima S, Coppen SR, et al. Heterogeneic nature of adult cardiac side population cells. Biochem Biophys Res Commun. 2008;371(4):615-620.[17] Carr CA, Stuckey DJ, Tan JJ, et al. Cardiosphere-Derived Cells Improve Function in the Infarcted Rat Heart for at Least 16 Weeks-an MRI Study. PLoS One.2011;6(10): e25669. [18] Davis DR, Ruckdeschel Smith R, Marban E, et al. Humancardiospheres are a source of stem cells with cardiomyogenic potential. Stem Cells. 2010;28(5):903- 904.[19] Ott HC, Matthiesen TS, Brechtken J, et al. The adult human heart as a source for stem cells:repair strategies with embryonic-like progenitor cells. Nat ClinPract Cardiovasc Med. 2007;4(1):S27-39.[20] Vieira JM, Riley PR. Epicardium-derived cells: a new source of regenerative capacity. Heart. 2011;97(1):15-19.[21] Urbanek K, Cesselli D, Rota M, et al. Stem cell niches in the adult mouse heart. PNAS. 2006;103(24): 9226-9231.[22] Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009; 324(5923): 98-102.[23] Smith RR, Barile L, Cho HC, et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007;115(7): 896-908.[24] D'Amario D, Fiorini C, Campbell PM, et al. Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res. 2011; 108(7):857-861.[25] 金秋,李一文.心脏原位干细胞修复心肌的研究[J].国际心血管病杂志, 2011, 38(2): 86-88. [26] Pouly J , Bruneval P , Mandet C, et al .Cardiac stem cells in the real world. J Thorac Cardiovasc Surg. 2008;135(3) : 673-678.[27] Itzhaki-Alfia A, Leor J, Raanani E, et al. Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells. Circulation.2009; 120(25): 2559-2566.[28] Mishra R, Vijayan K, Colletti EJ, et al. Characterization and functionality of cardiac progenitor cells in congenital heart patients. Circulation. 2011;123(4):364-373. [29] Kajstura J, Urbanek K, Rota M, et al. Cardiac stem cells and myocardial disease. J Mol Cell Cardiol.2008;45(4):505513.[30] Hosoda T, Rota M, Kajstura J, et al. Role of stem cells in cardiovascular biology. J Thromb Haemost.2011;9(1): 151161.[31] Kajstura J, Gurusamy N, Ogorek B, et al. Myocyte Turnover in the Aging Human Heart. Circ Res. 2010; 107(11): 1374-1386.[32] Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med. 2002;346(1):5-15. [33] van Vliet P, Roccio M, Smits AM, et al. Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Neth Heart J.2008;16(5):163-169.[34] Limana F, Capogrossi MC, Germani A. The epicardium in cardiac repair: From the stem cell view. Pharmacol Ther. 2011;129 (1) 82-96.[35] Leri A, Kajstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Soc. 2005; 265(4):142-154.[36] Arsalan M, Woitek F, Adams V, et al. Distribution of cardiac stem cells in the human heart. ISRN Cardiol. 2012; 483407:1-4.[37] Kurazumi H,Kubo M,Ohshima M, et al. The Effects of Mechanical Stress on the Growth, Differentiation, and Paracrine Factor Production of Cardiac Stem Cells. PLoS ONE. 2011;6 (12) e28890.[38] Tang YL, Zhu W, Cheng M, et al. Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarctionby inducing CXCR4 expression. Circ Res. 2009;104(10):1209-1216.[39] Bolli R, Chugh AR, D’Amario D, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011; 378 (9806):1847-1857.[40] Tan JJ, Carr CA, Stuckey DJ, et al. Isolation and Expansion of Cardiosphere-Derived Stem Cells. Biol Curr Prot Stem Cell Biol. 2011;16:2C.3.1-2C.3.12. [41] Abdel-Latif A, Bolli R, Tleyjeh IM, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007; 167 (10): 989-997.[42] 陈新云,曾智.干细胞治疗缺血性心脏病的主要问题[J].心血管病学进展, 2010,31(6): 908-909.[43] Johnston PV, Sasano T, Mills K, et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation. 2009; 120 (12):1075-1083.[44] 陈振,王联发,周文兵.干细胞移植治疗心脏病进展[J].疑难杂症. 2011,10(3):236-239.[45] Lee ST, White AJ, Matsushita S, et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol. 2011;57(4):445-465.[46] 皮淑芳,王怀祯,李彤,等.干细胞移植与心脏疾病治疗[J].生物医学工程与临床,2010,14(2):180-183.[47] Williams AR, Trachtenberg B, Velazquez DL, et al. Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy Functional Recovery and Reverse Remodeling. Circ Res. 2011; 108(7):792-796.[48] Zakharova L, Mastroeni D, Mutlu N, et al. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Cardiovasc Res. 2010; 87(1):40-49.[49] Li TS, Cheng K, Malliaras K, et al. Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repair . Cardiovasc Res. 2011;89(1):157-165. [50] Makkar RR, Smith RR, Cheng K, et al. Intracoronary cardiosphere- derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012;379(9819):895-904. [51] Maxeiner H,Krehbiehl N,Muller A, et al. New insights into paracrine mechanisms of human cardiac progenitor cells. Eur J Heart Fail. 2010;12(7):730-737. [52] Kawaguchi N, Smith AJ, Waring CD, et al. c-kit pos GATA-4 High Rat Cardiac Stem Cells Foster Adult Cardiomyocyte Survival through IGF-1 Paracrine Signalling. PLoS ONE.2010; 5(12): e14297.[53] Matsuura K,Honda A,Nagai T,et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J ClinInvest. 2009;119(8): 2204-2217.[54] Chimenti I, Smith RR, Li TS, et al. Relative Roles of Direct Regeneration Versus Paracrine Effects of Human Cardiosphere-Derived Cells Transplanted Into Infarcted Mice. Circ Res 2010; 106(5):971-80.[55] Chimenti I, Smith RR, Leppo MK, et al. Human cardiac progenitor cells secrete paracrine factors in vitro and in vivo. J Mol Cell Cardiol. 2008;44(4):802-803.[56] Tang XL, Rokosh G, Sanganalmath SK, et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation. 2010;121(2):293-305.[57] Zheng S, Zhou C, Weng Y, et al. Improvements of cardiac electrophysiologic stability and ventricular fibrillation threshold in rats with myocardial infarction treated with cardiac stem cells. Crit Care Med. 2011;39(5):1082-1088. |